Heart Exercise And Remote Technologies Trial
- Conditions
- Cardiovascular diseaseCardiovascular - Coronary heart diseasePhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationPublic Health - Other public health
- Registration Number
- ACTRN12611000117910
- Lead Sponsor
- Ralph Maddison
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 170
1. A clinically documented diagnosis of ischaemic heart disease (angina, myocardial infarction, revascularisation, including angioplasty, stent or coronary artery bypass graft) within the previous three to twelve months;
2. A current outpatient and is clinically stable
3. Able to perform exercise;
4. Able to understand and write English;
5. Own a mobile phone and have access to the internet.
1.Have been admitted to hospital with heart disease within the previous 6 weeks;
2.Have terminal cancer;
3.Have significant exercise limitations other than CVD, or currently meet the recommendations for regular physical activity (150 min/week moderate intensity activity).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in maximal oxygen uptake (VO2max) from baseline to 24 weeks.[Baseline and 24 weeks]
- Secondary Outcome Measures
Name Time Method Physical function measured with the 6-minute walk test[Baseline and 24 weeks];Total physical activity (MET-minutes per week) measured with the International Physical Activity Questionnaire (IPAQ)[Baseline and 24 weeks];Health related quality of life (SF-36)[Baseline and 24 weeks];Cost-effectiveness - Cost information, including cost of programme, and direct medical costs (including cost of treatment, primary care, secondary care and over-the-counter medications) and Quality Adjusted Life Year (QALY).[24 weeks]